Designing Bimetallic Metal‐Organic Framework‐Based Heterojunction Radiosensitizer for Enhanced Radiodynamic Therapy and Immunotherapy
Advanced Functional Materials · 2024-03 · 34 (11)
DOI: 10.1002/adfm.202312919 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Functional Materials, online erschienen am 03.12.2023. Verfasst von Zushuang Xiong und 8 weiteren Autor:innen. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 60 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Science Fund for Distinguished Young Scholars.
Abstract (Originalsprache)
Radiotherapy, as one of the most common strategies for clinical cancer treatment, suffers from failure due to the hypoxia, inflammation, and radiosensitivity difference of malignant tumors, side effects, and radioresistance. Heterojunction‐based radiosensitizers attract great attention to the lower excitation energy and remarkable catalytic activity as compared to typical transition metal radiosensitizers. However, the bio‐application of heterojunction radiosensitizers is in its infancy due to the challenges in structure engineering, rational energy band alignment, and ideal photogenerated carrier migration. Herein, a bimetallic metal‐organic framework (MOF)‐based heterojunction radiosensitizer is reasonably designed to enhance the radiodynamic therapeutic efficiency of Ru complex, and to activate natural killer (NK) cell‐mediated innate immune responses for promoted tumor immunotherapy. This study not only designs a novel bimetallic MOF‐based heterojunction structure but also elucidates the underlying action mechanisms in inhibiting cancer proliferation, which sheds light on the practicable design of radiosensitizers and the tumor combination treatment.
Förderung
- National Natural Science Foundation of China
- National Science Fund for Distinguished Young Scholars
Zitieren
APA
Xiong, Z., Yang, M., Liu, P., Tang, Z., Yang, Y., Zhan, M., Chen, T., Li, X., & Lu, L. (2024). Designing Bimetallic Metal‐Organic Framework‐Based Heterojunction Radiosensitizer for Enhanced Radiodynamic Therapy and Immunotherapy. Advanced Functional Materials, 34(11). https://doi.org/10.1002/adfm.202312919
Vancouver
Xiong Z, Yang M, Liu P, Tang Z, Yang Y, Zhan M, et al. Designing Bimetallic Metal‐Organic Framework‐Based Heterojunction Radiosensitizer for Enhanced Radiodynamic Therapy and Immunotherapy. Advanced Functional Materials. 2024;34(11). doi:10.1002/adfm.202312919
BibTeX
@article{Xiong2024,
author = {Xiong, Zushuang and Yang, Mingqi and Liu, Peixin and Tang, Zhiying and Yang, Yu and Zhan, Meixiao and Chen, Tianfeng and Li, Xiaoling and Lu, Ligong},
title = {Designing Bimetallic Metal‐Organic Framework‐Based Heterojunction Radiosensitizer for Enhanced Radiodynamic Therapy and Immunotherapy},
journal = {Advanced Functional Materials},
year = {2024},
volume = {34},
number = {11},
doi = {10.1002/adfm.202312919}
}
EUVIMED